{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-349141","form_type":"8-K","ticker":"KYNB","cik":"0000921299","company_name":"KYNTRA BIO, INC.","filed_at":"2026-08-13T20:05:16+00:00","discovered_at":"2026-08-13T20:07:00.108272+00:00","generated_at":"2026-08-13T20:07:19.014604+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Kyntra Bio Q2 2026 net income $12M vs year-ago loss; cash $95.7M, runway to 2028","bullets":["Net income from continuing ops $12.0M ($2.96/share) vs net loss $13.7M ($3.38/share) in Q2 2025.","Total revenue from continuing ops was negative $1.5M vs positive $1.3M in Q2 2025.","Cash, cash equivalents, investments, and accounts receivable $95.7M as of June 30, 2026; expected to fund operations into 2028.","FG-3246 Phase 2 interim analysis in mCRPC on track for 4Q 2026; roxadustat Phase 3 protocol finalized, initiation targeted 4Q 2026.","New MATTERHORN post hoc data at EHA 2026 showed transfusion independence benefit in LR-MDS with HTB."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-349141","json":"https://secwatch.observer/filing/0001193125-26-349141.json","markdown":"https://secwatch.observer/filing/0001193125-26-349141.md","text":"https://secwatch.observer/filing/0001193125-26-349141.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/921299/000119312526349141/0001193125-26-349141-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/921299/000119312526349141/kynb-20260813.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-13T20:07:19.014604+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}